First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives

Bibliography

• WINSLOW RM: Red cell substitutes. Semin. Hematol. (2007) 44(1):51-59.
   PubMed Web of Science ®Google Scholar
• ALAYASH AI: Oxygen therapeutics: can we tame haemoglobin? Nat. Rev. Drug Discov. (2004) 3(2):152-159.
   Google Scholar
• REISS JG: Oxygen carriers (‘blood substitutes’)-raison d’etre, chemistry, and some physiology. Chem. Rev. (2001) 101(9):2797-2919.
   PubMed Web of Science ®Google Scholar
• BOYKINS RA, BUEHLER PW, JIA Y, VENABLE R, ALAYASH AI: O-raffinose crosslinked hemoglobin lacks site-specific chemistry in the central cavity: structural and functional consequences of beta93Cys modification. Proteins (2005) 59(4):840-855.
   PubMed Web of Science ®Google Scholar
• BUEHLER PW, BOYKINS RA, JIA Y, NORRIS S, FREEDBERG DI, ALAYASH AI: Structural and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal. Chem. (2005) 77(11):3466-3478.
   PubMed Web of Science ®Google Scholar
• BUEHLER PW, BOYKINS RA, NORRIS S, ALAYASH AI: Chemical characterization of diaspirin cross-linked hemoglobin polymerized with poly(ethylene glycol). Anal. Chem. (2006) 78(13):4634-4641.
   PubMed Web of Science ®Google Scholar
• AMICONI G, ASCOLI F, BARRA D et al.: Selective oxidation of methionine beta(55)D6 at the alpha 1 beta 1 interface in hemoglobin completely destabilizes the T-state. J. Biol. Chem. (1989) 264(30):17745-17749.
   PubMed Web of Science ®Google Scholar
• VASQUEZ GB, KARAVITIS M, JI X et al.: Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces. Biophys. J. (1999) 76(1 Pt 1):88-97.
   PubMed Web of Science ®Google Scholar
• OTON J, BUCCI E, STEINER RF et al.: Molecular dynamics of hemoglobin subunits as seen by fluorescence spectroscopy. J. Biol. Chem. (1981) 256(14):7248-7256.
   PubMed Web of Science ®Google Scholar
• KHAN I, DANTSKER D, SAMUNI U et al.: Beta 93 modified hemoglobin: kinetic and conformational consequences. Biochemistry (2001) 40(25):7581-7592.
   PubMed Web of Science ®Google Scholar
• NAGABABU E, RAMASAMY S, RIFKIND JM, JIA Y, ALAYASH AI: Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry (2002) 41(23):7407-7415.
   PubMed Web of Science ®Google Scholar
• JIA Y, RAMASAMY S, WOOD F, ALAYASH AI, RIFKIND JM: Cross-linking with O-raffinose lowers oxygen affinity and stabilizes haemoglobin in a non-cooperative T-state conformation. Biochem. J. (2004) 384(Pt 2):367-375.
   PubMed Web of Science ®Google Scholar
• BALDWIN AL, WILEY EB, ALAYASH AI: Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers. J. Appl. Physiol. (2004) 96(3):893-903.
   PubMed Web of Science ®Google Scholar
• ABASSI Z, KOTOB S, PIERUZZI F et al.: Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. (1997) 129(6):603-610.
   PubMedGoogle Scholar
• JIA Y, BUEHLER PW, BOYKINS RA, VENABLE RM, ALAYASH AI: Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway. J. Biol. Chem. (2007) 282(7):4894-4907.
   PubMed Web of Science ®Google Scholar
• HUANG L, WOJCIECHOWSKI G, ORTIZ DE MONTELLANO PR: Role of heme-protein covalent bonds in mammalian peroxidases. Protection of the heme by a single engineered heme-protein link in horseradish peroxidase. J. Biol. Chem. (2006) 281(28):18983-18988.
   PubMed Web of Science ®Google Scholar
• OSAWA Y, DARBYSHIRE JF, MEYER CA, ALAYASH AI: Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents. Biochem. Pharmacol. (1993) 46(12):2299-305.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F, ALAYASH AI: Oxyhemoglobin and apoptosis. J. Neurosurg. (2000) 92(5):899-902.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F, ALAYASH AI: Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood (2001) 98(12):3315-3323.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F, WOOD F, PORRAS C, MACDONALD VW, ALAYASH AI: Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium. Biochim. Biophys. Acta (2000) 1495(2):150-159.
   PubMed Web of Science ®Google Scholar
• MCLEOD LL, ALAYASH AI: Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am. J. Physiol. (1999) 277:H92-H99.
   PubMed Web of Science ®Google Scholar
• YEH LH, ALAYASH AI: Effects of cell-free hemoglobin on hypoxia-inducible factor (HIF-1alpha) and heme oxygenase (HO-1) expressions in endothelial cells subjected to hypoxia. Antioxid. Redox Signal. (2004) 6(6):944-953.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F, ALAYASH AI: Interactions of hemoglobin with hydrogen peroxide alters intracellular thiol levels and the course of endothelial cell death. Am. J. Physiol. Heart Circ. Physiol. (2000) 279(4):H1880-H1889.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F: Redox active hemoglobin enhances lipopolysaccharide-induced injury to cultured bovine endothelial cells. Am. J. Physiol. Heart Circ. Physiol. (2004) 287(4):H1875-H1882.
   PubMed Web of Science ®Google Scholar
• D’AGNILLO F, ALAYASH AI: A role for the myoglobin redox cycle in the induction of endothelial cell apoptosis. Free Radic. Biol. Med. (2002) 33(8):1153-1164.
   PubMed Web of Science ®Google Scholar
• TOUSSAINT-HACQUARD M, DEVAUX Y, LONGROIS D et al.: Biological response of human aortic endothelial cells exposed to acellular hemoglobin solutions developed as potential blood substitutes. Life Sci. (2003) 72(10):1143-1157.
   PubMed Web of Science ®Google Scholar
• CHENG AM, MOORE EE, JOHNSON JL et al.: Polymerized hemoglobin induces heme oxygenase-1 protein expression and inhibits intercellular adhesion molecule-1 protein expression in human lung microvascular endothelial cells. J. Am. Coll. Surg. (2005) 201(4):579-584.
   PubMed Web of Science ®Google Scholar
• DULL RO, DEWITT BJ, DINAVAHI R et al.: Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J. Appl. Physiol. (2004) 97(5):1930-1937.
   PubMed Web of Science ®Google Scholar
• MOTTERLINI R, FORESTI R, VANDEGRIFF K, INTAGLIETTA M, WINSLOW RM: Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am. J. Physiol. (1995) 269(2 Pt 2):H648-H655.
   PubMed Web of Science ®Google Scholar
• INTAGLIETTA M, CABRALES P, TSAI AG: Microvascular perspective of oxygen-carrying and -noncarrying blood substitutes. Annu. Rev. Biomed. Eng. (2006) 8:289-321.
   Google Scholar
• BUEHLER PW, ALAYASH AI: Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion (2004) 44(10):1516-1528.
   PubMed Web of Science ®Google Scholar
• ALAYASH AI, FRATANTONI JC, BONAVENTURA C, BONAVENTURA J, CASHON RE: Nitric oxide binding to human ferrihemoglobins cross-linked between either alpha or beta subunits. Arch. Biochem. Biophys. (1993) 303(2):332-338.
   PubMed Web of Science ®Google Scholar
• DOHERTY DH, DOYLE MP, CURRY SR et al.: Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. (1998) 16(7):672-676.
   PubMed Web of Science ®Google Scholar
• BURHOP K, GORDON D, ESTEP T: Review of hemoglobin-induced myocardial lesions. Artif. Cells Blood Substit. Immobil. Biotechnol. (2004) 32(3):353-374.
   PubMed Web of Science ®Google Scholar
• REEDER BJ, SHARPE MA, KAY AD, KERR M, MOORE K, WILSON MT: Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem. Soc. Trans. (2002) 30(4):745-748.
   PubMed Web of Science ®Google Scholar
• HOLT S, REEDER B, WILSON M et al.: Increased lipid peroxidation in patients with rhabdomyolysis. Lancet (1999) 353(9160):1241.
   PubMed Web of Science ®Google Scholar
• MOORE KP, HOLT SG, PATEL RP et al.: A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. (1998) 273(48):31731-31737.
   PubMed Web of Science ®Google Scholar
• KUBULUS D, RENSING H, PAXIAN M et al.: Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock. Crit. Care Med. (2005) 33(3):629-637.
   PubMed Web of Science ®Google Scholar
• PRZYBOCKI JM, MCCALDEN TA, COLLIER JM, BILLINGS RE: Hepatic inflammatory responses to alphaalpha-cross-linked hemoglobin infusion in rats. J. Lab. Clin. Med. (1998) 131(5):432-441.
   PubMedGoogle Scholar
• D’AGNILLO F, CHANG TM: Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase-catalase. Free Radic. Biol. Med. (1998) 24(6):906-912.
   Web of Science ®Google Scholar
• MOTTERLINI R, MACDONALD VW: Cell-free hemoglobin potentiates acetylcholine-induced coronary vasoconstriction in rabbit hearts. J. Appl. Physiol. (1993) 75:2224-2233.
   PubMed Web of Science ®Google Scholar
• CABRALES P, TSAI AG, INTAGLIETTA M: Deferoxamine lowers tissue damage after 80% exchange transfusion with polymerized hemoglobin. Antioxid. Redox Signal. (2007) 9:1-10.
   Google Scholar
• KANNER J, HAREL S: Desferrioxamine as an electron donor. Inhibition of membranal lipid peroxidation initiated by H2O2-activated metmyoglobin and other peroxidizing systems. Free Radic. Res. Commun. (1987) 3(1-5):309-317.
   PubMedGoogle Scholar
• FAIVRE B, MENU P, LABRUDE P, GRANDGEORGE M, VIGNERON C: Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin. Artif. Cells Blood Substit. Immobil. Biotechnol. (1994) 22(3):551-558.
   PubMed Web of Science ®Google Scholar
• DUNNE J, CARON A, MENU P et al.: Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem. J. (2006) 399(3):513-524.
   Google Scholar
• WERNERMAN J, LUO JL, HAMMARQVIST F: Glutathione status in critically-ill patients: possibility of modulation by antioxidants. Proc. Nutr. Soc. (1999) 58(3):677-680.
   PubMed Web of Science ®Google Scholar
• ROBINSON MK, ROUNDS JD, HONG RW, JACOBS DO, WILMORE DW: Glutathione deficiency increases organ dysfunction after hemorrhagic shock. Surgery (1992) 112(2):140-147.
   PubMed Web of Science ®Google Scholar
• PALACE V, KUMAR D, HILL MF, KHAPER N, SINGAL PK: Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J. Mol. Cell Cardiol. (1999) 31(1):193-202.
   PubMed Web of Science ®Google Scholar
• PRZYBELSKI R, DAILY E, KISICKI J, MATTIA-GOLDBERG C, BOUNDS MJ, COLBURN WA: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit. Care Med. (1996) 24:1993-2000.
   PubMed Web of Science ®Google Scholar
• SAXENA R, WIJNHOUND AD, CARTON H et al.: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 30:993-996.
   PubMed Web of Science ®Google Scholar
• SLOAN EP, KOENIGSBER M, GENS D et al.: Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA (1999) 282:1857-1864.
   PubMed Web of Science ®Google Scholar
• ALAYASH AI, RYAN BA, FRATANTONI JC: Oxidation reactions of human, opossum (Didelphis virginiana) and spot (Leiostomus xanthurus) hemoglobins: a search for a correlation with some structural-functional properties. Comp. Biochem. Physiol. B (1993) 106(2):427-432.
   Google Scholar
• DOU YI, MAILLETT DH, EICH RF, OLSON JS: Myoglobin as a model system for designing heme protein based blood substitutes. Biophys. Chem. (2002) 98(1-2):127-148.
   PubMed Web of Science ®Google Scholar
• ALAYASH AI, RYAN BA, EICH RF, OLSON JS, CASHON RE: Reactions of sperm whale myoglobin with hydrogen peroxide: effects of distal pocket mutations on formation and stability of the ferryl intermediate. J. Biol. Chem. (1999) 274(4):2029-2037.
   PubMed Web of Science ®Google Scholar
• RAAT NJ, DOYLE MP, BURHOP KE, KLEIN J, INCE C: Effects of recombinant-hemoglobin solutions rHb2.0 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J. Lab. Clin. Med. (2005) 145(1):21-32.
   PubMedGoogle Scholar
• WINSLOW RM: Current status of oxygen carriers (‘blood substitutes’): 2006. Vox Sang. (2006) 92(2):102-110.
   Google Scholar
• HACKERT ML, RIGGS AF: When size matters. Structure (2006) 14(7):1094-1096.
   PubMed Web of Science ®Google Scholar
• CHIANCONE E, BRENOWITZ M, ASCOLI F, BONVENTURA C, BONVENTURA J: Amphitrite oranta erythrocruorin. I. Structural properties and characterization of subunit interactions. Biochim. Biophys. Acta (1980) 623(1):146-162.
   PubMed Web of Science ®Google Scholar
• HIRSCH RE, JELICKS LA, WITTENBERG BA, KAUL DK, SHEAR HJ, HARRINGTON JP: A first evaluation of natural high molecular weight polymeric Lumbricus terrestris hemoglobin as an oxygen carrier. Artif. Cells Blood Substit. Immobil. Biotechnol. (1997) 25(5):429-444.
   PubMed Web of Science ®Google Scholar
• SCHAER DJ, SCHAER CA, BUEHLER PW et al.: CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptaglobin. Blood (2006) 107(1):373-380.
   PubMed Web of Science ®Google Scholar
• MCGOWN EL, LYONS MF, MARINI MA, ZEGNA A: Reduction of extracellular methemoglobin by erythrocytes. Biochim. Biophys. Acta (1990) 1036:202-206.
   Google Scholar
• SU D, MAY JM, KOURY MJ, ASARD H: Human erythrocyte membranes contain a cytochrome B561 that may be involved in extracellular ascorbate recycling. J. Biol. Chem. (2006) 281(52):39852-39859.
   PubMed Web of Science ®Google Scholar
• BALDWIN AL, WILEY EB, SUMMERS AG, ALAYASH AI: Sodium selenite reduces hemoglobin-induced venular leakage in the rat mesentery. Am. J. Physiol. (2003) 284(1):H88-H91.
   Google Scholar
• D’AGNILLO F, CHANG TMS: Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat. Biotechnol. (1998) 16(7):667-671.
   PubMed Web of Science ®Google Scholar
• BUEHLER PW, HANEY CR, GULATI A, MA L, HSIA CJ: Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms. Free Radic. Biol. Med. (2004) 37(1):124-135.
   PubMed Web of Science ®Google Scholar
• SIMONI J, SIMONI G, WESSON DE, GRISWOLD JA, FEOLA M: A novel hemoglobin-adenosine-glutathione based blood substitute: evaluation of its effects on human blood ex vivo. ASAIO (2000) 46(6):679-692.
   PubMed Web of Science ®Google Scholar